Gryphon Financial Partners’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,135
Closed -$181K 172
2019
Q1
$181K Buy
+1,135
New +$181K 0.05% 120
2018
Q3
Sell
-366
Closed -$57K 706
2018
Q2
$57K Buy
+366
New +$57K 0.03% 207